Lu Hao - Search Results

Year	Number of Results
2003	1
2004	5
2005	4
2006	3
2007	10
2008	11
2009	12
2010	13
2011	12
2012	27
2013	25
2014	31
2015	40
2016	62
2017	68
2018	73
2019	84
2020	101
2021	123
2022	139
2023	163
2024	82

1

A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma.

Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, Gao C, Lu H, Wang X, Cao P, Chen H, Lu S, Zhou G. Lu Y, et al. Among authors: lu h. Nat Commun. 2022 Aug 6;13(1):4594. doi: 10.1038/s41467-022-32283-3. Nat Commun. 2022. PMID: 35933472 Free PMC article.

2

Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.

Dong Z, Hou L, Luo W, Pan LH, Li X, Tan HP, Wu RD, Lu H, Yao K, Mu MD, Gao CS, Weng XY, Ge JB. Dong Z, et al. Among authors: lu h. Eur Heart J. 2024 Mar 1;45(9):669-684. doi: 10.1093/eurheartj/ehad787. Eur Heart J. 2024. PMID: 38085922

3

Gut microbiota and Sjögren's syndrome: a two-sample Mendelian randomization study.

Cao Y, Lu H, Xu W, Zhong M. Cao Y, et al. Among authors: lu h. Front Immunol. 2023 Jun 13;14:1187906. doi: 10.3389/fimmu.2023.1187906. eCollection 2023. Front Immunol. 2023. PMID: 37383227 Free PMC article.

4

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.

Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S, Zhou Y, Hu Y, Shi B, Ge J. Zhao Y, et al. Among authors: lu h. Signal Transduct Target Ther. 2023 Nov 20;8(1):431. doi: 10.1038/s41392-023-01652-9. Signal Transduct Target Ther. 2023. PMID: 37981648 Free PMC article. Review.

5

Index Networks.

Lu H, Dai Y, Shen C, Xu S. Lu H, et al. IEEE Trans Pattern Anal Mach Intell. 2022 Jan;44(1):242-255. doi: 10.1109/TPAMI.2020.3004474. Epub 2021 Dec 7. IEEE Trans Pattern Anal Mach Intell. 2022. PMID: 32750793

6

Lutetium Lu 177 vipivotide tetraxetan for prostate cancer.

Liu X, Fang GC, Lu H, Shi ZD, Chen ZS, Han CH. Liu X, et al. Among authors: lu h. Drugs Today (Barc). 2023 Jan;59(1):37-49. doi: 10.1358/dot.2023.59.1.3476574. Drugs Today (Barc). 2023. PMID: 36811416 Review.

7

The Ninj1/Dusp1 Axis Contributes to Liver Ischemia Reperfusion Injury by Regulating Macrophage Activation and Neutrophil Infiltration.

Hu Y, Zhan F, Wang Y, Wang D, Lu H, Wu C, Xia Y, Meng L, Zhang F, Wang X, Zhou S. Hu Y, et al. Among authors: lu h. Cell Mol Gastroenterol Hepatol. 2023;15(5):1071-1084. doi: 10.1016/j.jcmgh.2023.01.008. Epub 2023 Jan 31. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36731792 Free PMC article.

8

Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.

Ni WJ, Zhou H, Lu H, Ma NN, Hou BB, Li W, Kong FX, Yu JT, Hou R, Jin J, Wen JG, Zhang T, Meng XM. Ni WJ, et al. Among authors: lu h. Clin Transl Med. 2023 Aug;13(8):e1359. doi: 10.1002/ctm2.1359. Clin Transl Med. 2023. PMID: 37537731 Free PMC article.

9

JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice.

Tian J, Cai M, Jin S, Chen Q, Xu J, Guo Q, Yan Z, Han X, Lu H. Tian J, et al. Among authors: lu h. Pharm Biol. 2023 Dec;61(1):647-656. doi: 10.1080/13880209.2023.2188549. Pharm Biol. 2023. PMID: 37038833 Free PMC article.

10

2020 Roadmap on Zinc Metal Batteries.

Xu C, Zhang Y, Zhang N, Liu X, Yi J, Liu X, Lu X, Ru Q, Lu H, Peng X, Zhao XS, Ma J. Xu C, et al. Among authors: lu h. Chem Asian J. 2020 Nov 16;15(22):3696-3708. doi: 10.1002/asia.202000946. Epub 2020 Oct 20. Chem Asian J. 2020. PMID: 32851776 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

970 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

970 results

Results by year